EUROFINS CLINICAL GENETICS UK LIMITED
Get an alert when EUROFINS CLINICAL GENETICS UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-14 (in 3mo)
Last made up 2025-07-31
Watchouts
None on the register
Cash
£1K
-97.9% vs 2023
Net assets
£42K
-90.3% vs 2023
Employees
6
-57.1% vs 2023
Profit before tax
-£582K
+78.5% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £2,055,000 | £1,478,000 | |
| Operating profit | -£2,684,000 | -£545,000 | |
| Profit before tax | -£2,705,000 | -£582,000 | |
| Net profit | -£2,746,000 | -£563,000 | |
| Cash | £48,000 | £1,000 | |
| Total assets less current liabilities | £876,000 | £85,000 | |
| Net assets | £431,000 | £42,000 | |
| Equity | £431,000 | £42,000 | |
| Average employees | 14 | 6 | |
| Wages | £1,051,000 | £334,000 | |
| Directors' remuneration | £81,000 | £18,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-28.1%
£2,055,000 £1,478,000
-
Cash
-97.9%
£48,000 £1,000
-
Net assets
-90.3%
£431,000 £42,000
-
Employees
-57.1%
14 6
-
Operating profit
+79.7%
-£2,684,000 -£545,000
-
Profit before tax
+78.5%
-£2,705,000 -£582,000
-
Wages
-68.2%
£1,051,000 £334,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -130.6% | -36.9% | |
| Net margin | -133.6% | -38.1% | |
| Return on capital employed | -306.4% | -641.2% | |
| Current ratio | 0.99x | 0.70x | |
| Interest cover | -52.63x | -12.11x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- EUROFINS CLINICAL GENETICS UK LIMITED 2023-12-01 → present
- EUROFINS BIOMNIS UK LIMITED 2017-07-03 → 2023-12-01
- BIOMNIS LABORATORIES UK LIMITED 2010-06-08 → 2017-07-03
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Constantin
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have no reason to believe that a material uncertainty exists that may cast significant doubt the ability of this company to continue as a concern or its ability to continue with current financing arrangements. A new Managing Director was brought into the business towards the end of 2024 with a view to driving sustained profitable growth into 2025. Whilst driving further cost cutting and securing of new contracts the business is on a platform to be successful into 2025 and beyond.”
Significant events
- “There were no adjusting events after the balance sheet date.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GANDERTON, Laura Jayne | Secretary | 2023-01-20 | — | — |
| O'SULLIVAN, John Mark | Director | 2025-04-14 | Feb 1963 | Irish |
| VINE, Sam Francis | Director | 2024-12-16 | May 1990 | British |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KAYE, Gavin Mark | Secretary | 2010-06-08 | 2016-03-23 |
| MILES, Sonia | Secretary | 2022-04-01 | 2023-01-20 |
| MILLS, Alice Irene | Secretary | 2016-03-23 | 2022-03-31 |
| CAMPBELL, Mark William | Director | 2010-10-01 | 2012-06-15 |
| CARTON, Olivier Daniel | Director | 2010-06-08 | 2013-02-04 |
| CHIPPERFIELD, Simon Charles | Director | 2010-06-08 | 2012-06-15 |
| GUIAVARCH, Pierre-Yves | Director | 2010-06-08 | 2013-02-04 |
| HARTNETT, Michael Thomas | Director | 2023-03-31 | 2024-03-31 |
| KOHLI, Amit | Director | 2017-06-19 | 2018-09-28 |
| MILLS, Alice Irene | Director | 2016-03-23 | 2022-05-06 |
| O'SULLIVAN, John Mark | Director | 2013-02-04 | 2023-03-31 |
| VAN DORP, Rob | Director | 2024-03-25 | 2025-03-18 |
| WATTS, Michael Robert | Director | 2022-05-06 | 2024-12-16 |
| WOLER, Charles | Director | 2013-02-04 | 2016-11-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Eurofins Scientific S.E. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-06-30 | Active |
Filing timeline
Last 20 of 76 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-12-01 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-31 | SH01 | capital | Capital allotment shares | |
| 2025-11-10 | RP01CS01 | confirmation-statement | Replacement filing of confirmation statement with made up date | |
| 2025-08-11 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-06-19 | AA | accounts | Accounts with accounts type full | |
| 2025-04-16 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-19 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-03 | CH01 | officers | Change person director company with change date | |
| 2024-12-16 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-16 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-22 | SH01 | capital | Capital allotment shares | |
| 2024-08-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-05-17 | AA | accounts | Accounts with accounts type full | |
| 2024-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-27 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-19 | SH01 | capital | Capital allotment shares | |
| 2023-12-01 | CERTNM | change-of-name | Certificate change of name company | |
| 2023-08-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-21 | AA | accounts | Accounts with accounts type full | |
| 2023-03-31 | AP01 | officers | Appoint person director company with name date | |
| 2023-03-31 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.